Nanomedicine: Nanotechnology, Biology, and Medicine

SJR Rank #6,376H-index: 166SJR: 0.845Best quartile: Q1APC: US$3,670
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmaceutical ScienceQ1
  • BioengineeringQ2
  • Biomedical EngineeringQ2
  • Materials Science (miscellaneous)Q2
  • Medicine (miscellaneous)Q2
  • Molecular MedicineQ2
  • Nanoscience and NanotechnologyQ2

Areas: Biochemistry, Genetics and Molecular Biology · Chemical Engineering · Engineering · Materials Science · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesGraphene and Nanomaterials ApplicationsNanoparticles: synthesis and applicationsAdvanced Drug Delivery SystemsImmunotherapy and Immune ResponsesDiverse Scientific and Economic StudiesDendrimers and Hyperbranched Polymers

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs080160240320

Documents per Year

2022202503570105140

Detailed Information

ISSN

1549-9634, 1549-9642

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.97

References per Document

59.99

Coverage

2005-2026

Scope

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.

Metrics from SCImago Journal Rank 2025. View on SCImago